论文信息 - A phase 1 b clinical trial of the CD 40-activating antibody CP-870 , 893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma - 字舞流文

A phase 1 b clinical trial of the CD 40-activating antibody CP-870 , 893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma

Y. Oki | E. Shpall | Y. Nieto | M. Qazilbash | C. Pinnix | A. Alousi | R. Champlin | B. Dabaja | M. Fanale | R. Talpur | S. Ciurea | M. Donato | R. Bassett | F. Maadani